• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [18635 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2020     Norwegian Institute of Public Health (NIPH) Safety, clinical effectiveness, predictive accuracy and cost effectiveness of blood based tests for women with suspected preeclampsia: a health technology assessment
2020     Center for Evidence-based Practice (CEP) COVID-19: high flow nasal cannula (HFNC)/non-invasive positive pressure ventilation (NIPPV) indications
2020     Center for Evidence-based Practice (CEP) COVID-19: proning considerations for patients on HFNC or BIPAP
2020     Center for Evidence-based Practice (CEP) COVID-19: criteria for advising home care patients to return to the hospital
2020     NIHR Health Services and Delivery Research programme Stroke Sentinel Audit Programme: Investigating and Evaluating Stroke Therapy (SSNAPIEST)
2020     Norwegian Institute of Public Health (NIPH) Intracoronary lithotripsy for the treatment of coronary artery disease: a health technology assessment
2020     Center for Evidence-based Practice (CEP) COVID-19: surge triage for suspected influenza-like illness
2020     NIHR Health Services and Delivery Research programme An evaluation of a multifaceted intervention to reduce antimicrobial prescribing in care home residents [REducing Antimicrobials in Care Homes (REACH)]: a non-randomised feasibility study and process evaluation
2020     Norwegian Institute of Public Health (NIPH) Disease modifying drugs for treatment of primary progressive multiple sclerosis: A health technology assessment
2020     NIHR Health Services and Delivery Research programme UK Study of tendon Achilles Rehabilitation multicentre randomised clinical trial (UK STAR)
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: pharmacological treatment of sexually transmitted and blood-borne infections ─ infections caused by chlamydia trachomatis and neisseria gonorrhoeae]
2020     NIHR Health Technology Assessment programme Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation
2020     NIHR Health Services and Delivery Research programme IMPlementation of A Relatives Toolkit (IMPART study): examining the critical success factors, barriers and facilitators to implementation of an online supported self-management intervention in the NHS
2020     NIHR Health Technology Assessment programme Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation
2020     Austrian Institute for Health Technology Assessment (AIHTA) Update PET/PET-CT evidence for need based planning in the area of oncology
2020     NIHR Health Technology Assessment programme Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation
2020     NIHR Health Technology Assessment programme Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation
2020     Austrian Institute for Health Technology Assessment (AIHTA) Proton and carbon ion therapy - an update on indications
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Endovascular treatment of varicose veins by radiofrequency ablation or cyanoacrylate closure]
2020     NIHR Health Technology Assessment programme Oral splints for patients with temporomandibular disorders or bruxism: a systematic review and economic evaluation
2020     NIHR Health Technology Assessment programme Interventions to reduce the risk of surgically transmitted Creutzfeldt–Jakob disease: a cost-effective modelling review
2020     Malaysian Health Technology Assessment (MaHTAS) Pre-dialysis education programme (PDEP)
2020     Malaysian Health Technology Assessment (MaHTAS) Diagnostic approaches to solitary pulmonary nodule (SPN)
2020     Malaysian Health Technology Assessment (MaHTAS) Cinacalcet for the treatment of secondary hyperparathyroidism in end stage renal failure and economic evaluation
2020     Malaysian Health Technology Assessment (MaHTAS) Influenza vaccination for the elderly and economic evaluation
2020     Swiss Federal Office of Public Health (FOPH) Olmesartan mono- and combination therapy in patients with essential hypertension
2020     Malaysian Health Technology Assessment (MaHTAS) Intravenous iron for iron deficiency anaemia
2020     Swiss Federal Office of Public Health (FOPH) Treatment of non-erosive gastroesophageal reflux disease patients with proton pump inhibitor therapy
2020     Malaysian Health Technology Assessment (MaHTAS) Programmatic management of latent tuberculosis infection
2020     Malaysian Health Technology Assessment (MaHTAS) Automatic guided vehicles (AGVs) for transportation of food and materials in hospitals
2020     NIHR Health Technology Assessment programme Seizure first aid training for people with epilepsy attending emergency departments and their significant others: the SAFE intervention and feasibility RCT
2020     Malaysian Health Technology Assessment (MaHTAS) Digital dental impression
2020     Malaysian Health Technology Assessment (MaHTAS) Biocompatible peritoneal dialysis (PD) solution
2020     Swiss Federal Office of Public Health (FOPH) Iron therapy for iron deficiency without anemia
2020     Health Technology Wales (HTW) Autologous haematopoietic stem cell transplantation for previously treated, relapsing-remitting multiple sclerosis
2020     Health Technology Wales (HTW) Pre-operative cardiopulmonary exercise testing for people in whom major abdominal surgery is planned
2020     Health Technology Wales (HTW) Rapid antigen detecting tests for diagnosing group A streptococcal infections in the community pharmacy setting
2020     NIHR Health Technology Assessment programme Understanding the health-care experiences of people with sickle cell disorder transitioning from paediatric to adult services: This Sickle Cell Life, a longitudinal qualitative study
2020     Health Technology Wales (HTW) Transcatheter aortic valve implantation (TAVI) for the treatment of patients with severe symptomatic aortic stenosis who are at intermediate surgical risk
2020     Health Technology Wales (HTW) Point of care haemolysis detection in blood samples that may be deemed unfit for laboratory analysis
2020     NIHR Health Technology Assessment programme Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Effectiveness and safety of the left ventricular assist device (LVAD) as destination therapy in paediatric patients]
2020     NIHR Health Technology Assessment programme An app-, web- and social support-based weight loss intervention for adults with obesity: the HelpMeDoIt! feasibility RCT
2020     NIHR Health Services and Delivery Research programme The effects of interoperable information technology networks on patient safety: a realist synthesis
2020     European Network for Health Technology Assessment (EUnetHTA) Rolling Collaborative Review COVID-19 - Lopinavir + Ritonavir
2020     NIHR Health Services and Delivery Research programme Social norms interventions to change clinical behaviour in health workers: a systematic review and meta-analysis
2020     Belgian Health Care Knowledge Centre (KCE) Polyvalent immunoglobulins – Part 2: use in Belgium
2020     NIHR Health Technology Assessment programme Gabapentin to reduce pain in women aged between 18 and 50 years with chronic pelvic pain: the GaPP2 RCT
2020     Malaysian Health Technology Assessment (MaHTAS) Prophylactic anticoagulation in ambulatory cancer patients
2020     NIHR Health Technology Assessment programme Ursodeoxycholic acid to reduce adverse perinatal outcomes for intrahepatic cholestasis of pregnancy: the PITCHES RCT
2020     Norwegian Institute of Public Health (NIPH) [Intermittent pneumatic compression for preventing deep vein thrombosis in acute stroke, a health technology assessment]
2020     Malaysian Health Technology Assessment (MaHTAS) Antifibrotic for treatment of idiopathic pulmonary fibrosis
2020     Norwegian Institute of Public Health (NIPH) [Effectiveness of microwave thermotherapy (TUMT) compared to transurethral resection of the prostate (TURP) for benign prostatic hyperplasia]
2020     Malaysian Health Technology Assessment (MaHTAS) Needleless Vacutainer system for blood collection
2020     NIHR Health Services and Delivery Research programme Variations in the organisation of Early Pregnancy Assessment Units (EPAUs) in the UK and their effects on clinical, service and patient-centred outcomes (VESPA)
2020     NIHR Health Technology Assessment programme Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation
2020     National Committee for Technology Incorporation (CONITEC) [Dolutegravir for the treatment of pregnant women living with HIV]
2020     National Committee for Technology Incorporation (CONITEC) [Baricitinib (Olumiant) for patients with moderate to severe active rheumatoid arthritis]
2020     NIHR Health Technology Assessment programme A systematic review of psychological interventions to improve motivation for self-management in people with type 1 and type 2 diabetes
2020     National Committee for Technology Incorporation (CONITEC) [Mirabegron for the treatment of storage dysfunction in patients with neurogenic bladder]
2020     NIHR Health Services and Delivery Research programme Using co-production to improve patient carer and staff experiences in health care organizations: a multi-centre, mixed methods evaluation in inpatient stroke units (CREATE)
2020     National Committee for Technology Incorporation (CONITEC) [Antimuscarinics (oxybutynin, tolterodine, solifenacin and darifenacin) for the treatment of storage dysfunction in patients with neurogenic bladder]
2020     National Committee for Technology Incorporation (CONITEC) [Photodynamic therapy for non-melanoma skin cancer]
2020     National Committee for Technology Incorporation (CONITEC) [Newborn screening for congenital toxoplasmosis]
2020     NIHR Public Health Research (PHR) programme A woman-centred, tailored SMS-delivered multi-component intervention for weight loss and maintenance of weight loss in the postpartum period: intervention adaptation and pilot RCT
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Brigatinib (non-small cell lung cancer) - Addendum to Commission A20-42]
2020     National Committee for Technology Incorporation (CONITEC) [Riociguat for inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension after surgical treatment]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ozanimod (relapsing remitting multiple sclerosis) - Benefit assessment according to §35a Social Code Book V]
2020     National Committee for Technology Incorporation (CONITEC) [Orlistat for weight loss in overweight or obese patients]
2020     NIHR Public Health Research (PHR) programme A two arm feasibility trial of lifestyle information and Slimming World groups to promote weight management and positive lifestyle behaviour in postnatal women from an ethnically diverse inner city population
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Caplacizumab (acquired thrombotic thrombocytopenic purpura) - Assessment according to §35a (1), Sentence 11, Social Code Book V]
2020     National Committee for Technology Incorporation (CONITEC) [Sibutramine for the treatment of obese patients]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Venetoclax (chronic lymphocytic leukaemia) - Addendum to Commission A20-39]
2020     National Committee for Technology Incorporation (CONITEC) [Empagliflozin and dapagliflozin for the treatment of type 2 diabetes mellitus]
2020     NIHR Health Services and Delivery Research programme Evaluating the use of patient experience data to improve the quality of inpatient mental health care
2020     NIHR Health Technology Assessment programme Interventions based on early intensive applied behaviour analysis for autistic children: a systematic review and cost-effectiveness analysis
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Osilodrostat (endogenous Cushing syndrome) - Assessment according to §35a (1), Sentence 11, Social Code Book V]
2020     National Committee for Technology Incorporation (CONITEC) [Rifapentine plus isoniazid for treatment of latent mycobacterium tuberculosis infection (LTBI)]
2020     NIHR Health Technology Assessment programme An extended stroke rehabilitation service for people who have had a stroke: the EXTRAS RCT
2020     NIHR Health Technology Assessment programme Robot-assisted training compared with an enhanced upper limb therapy programme and with usual care for upper limb functional limitation after stroke: the RATULS three-group RCT
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Darolutamide (prostate cancer) - Addendum to Commission A20-43]
2020     National Committee for Technology Incorporation (CONITEC) [Tofacitinib citrate for the treatment of moderate to severe ulcerative colitis in adult patients with inadequate response, loss of response or intolerance to previous treatment with conventional synthetic or biological drugs]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Brigatinib (non-small cell lung cancer) - Addendum to Commission A20-42]
2020     National Committee for Technology Incorporation (CONITEC) [Expansion of the use of sirolimus for the treatment of adult patients with lymphangioleiomyomatosis]
2020     NIHR Public Health Research (PHR) programme The effectiveness of promotional campaigns associated with revised UK drinking guidelines: a prospective evaluation
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Onasemnogene abeparvovec (spinal muscular atrophy) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2020     National Committee for Technology Incorporation (CONITEC) [Targeted therapies (vemurafenib, dabrafenib, cobimetinib, trametinib) and immunotherapies (ipilimumab, nivolumab, pembrolizumab) for the first-line treatment of advanced (unresectable and metastatic) melanoma]
2020     NIHR Health Technology Assessment programme Computerised speech and language therapy or attention control added to usual care for people with long-term post-stroke aphasia: the Big CACTUS three-arm RCT
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tezacaftor/ivacaftor (combination with ivacaftor; cystic fibrosis, 12 years and older, F508del mutation, homozygous) - Benefit assessment according to §35a Social Code] Book V
2020     NIHR Health Technology Assessment programme Risk-based, 6-monthly and 24-monthly dental check-ups for adults: the INTERVAL three-arm RCT
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Upadacitinib (rheumatoid arthritis) - Benefit assessment according to §35a Social Code Book V]
2020     National Committee for Technology Incorporation (CONITEC) [Personal frequency modulation system for hearing-impaired students at any age and at any academic level]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Givosiran (acute hepatic porphyria) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2020     National Committee for Technology Incorporation (CONITEC) [Cytoreductive surgery with hyperthermic chemotherapy in patients with malignant peritoneal mesothelioma]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Insulin glargine/lixisenatide (type 2 diabetes mellitus) - Benefit assessment according to §35a Social Code Book V]
2020     National Committee for Technology Incorporation (CONITEC) [Cytoreductive surgery (peritonectomy) with hyperthermic intraperitoneal chemotherapy (HIPEC)]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Venetoclax (chronic lymphocytic leukaemia) - Benefit assessment according to §35a Social Code Book V]
2020     National Committee for Technology Incorporation (CONITEC) [Exclusion of rifampicin for chemoprophylaxis for contacts of patients with Hansen´s disease]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Development of scientific concepts for the generation of routine practice data and their analysis for the benefit assessment of drugs according to §35a Social Code Book V – rapid report]
2020     National Committee for Technology Incorporation (CONITEC) [Ruxolitinib for the treatment of patients with primary myelofibrosis, post-polycythaemia vera myelofibrosis or post-essential thrombocythaemia myelofibrosis, in people with intermediate-2 or high-risk disease]